{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:17:02Z","timestamp":1752229022197},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurosurgery Clinics of North America"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.nec.2012.04.007","type":"journal-article","created":{"date-parts":[[2012,6,5]],"date-time":"2012-06-05T15:15:19Z","timestamp":1338909319000},"page":"515-523","source":"Crossref","is-referenced-by-count":19,"title":["High-Grade Gliomas in Children"],"prefix":"10.1016","volume":"23","author":[{"given":"Tene A.","family":"Cage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daphne","family":"Haas-Kogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nalin","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nec.2012.04.007_bib1","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJM199412013312207","article-title":"Brain tumors in children","volume":"331","author":"Pollack","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.nec.2012.04.007_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jnen\/61.3.215","article-title":"The WHO classification of tumors of the nervous system","volume":"61","author":"Kleihues","year":"2002","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.nec.2012.04.007_bib3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3171\/foc.2003.14.2.2","article-title":"Pediatric supratentorial high-grade gliomas","volume":"14","author":"Tamber","year":"2003","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.nec.2012.04.007_bib4","series-title":"2009-2010 CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in eighteen states in 2002-2006","year":"2009"},{"key":"10.1016\/j.nec.2012.04.007_bib5","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.ijrobp.2010.03.013","article-title":"Glioblastoma in children: a single-institution experience","volume":"80","author":"Perkins","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.nec.2012.04.007_bib6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00381-008-0631-7","article-title":"Radiation-induced brain tumours after central nervous system irradiation in childhood: a review","volume":"24","author":"Pettorini","year":"2008","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.nec.2012.04.007_bib7","first-page":"5358","article-title":"A\u00a0cancer family syndrome in twenty-four kindreds","volume":"48","author":"Li","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.nec.2012.04.007_bib8","first-page":"3245","article-title":"Germ-line\u00a0mutations of TP53 in Li-Fraumeni families: an extended study of 39 families","volume":"57","author":"Varley","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.nec.2012.04.007_bib9","first-page":"2011","article-title":"The pathoetiology of neurofibromatosis 1","volume":"178","author":"Jouhilahti","year":"1932","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nec.2012.04.007_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/BF02616938","article-title":"Malignant tumors of the central nervous system associated with familial polyposis of the colon: report of two cases","volume":"2","author":"Turcot","year":"1959","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.nec.2012.04.007_bib11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1227\/01.NEU.0000375513.12925.5C","article-title":"Glioblastomas with giant cell and sarcomatous features in patients with Turcot syndrome type 1: a clinicopathological study of 3 cases","volume":"67","author":"Lusis","year":"2010","journal-title":"Neurosurgery"},{"key":"10.1016\/j.nec.2012.04.007_bib12","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/ijc.26083","article-title":"Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas","volume":"129","author":"Felsberg","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nec.2012.04.007_bib13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3171\/2009.5.PEDS08422","article-title":"Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas","volume":"4","author":"Ranger","year":"2009","journal-title":"J\u00a0Neurosurg Pediatr"},{"key":"10.1016\/j.nec.2012.04.007_bib14","first-page":"67","article-title":"Pediatric gliomas. Recent results","volume":"171","author":"Pfister","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.nec.2012.04.007_bib15","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3171\/ped.2006.105.5.418","article-title":"Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children\u2019s Cancer Group 945 cohort","volume":"105","author":"Pollack","year":"2006","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.nec.2012.04.007_bib16","first-page":"7404","article-title":"Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort","volume":"61","author":"Pollack","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.nec.2012.04.007_bib17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1056\/NEJMoa012224","article-title":"Expression of p53 and prognosis in children with malignant gliomas","volume":"346","author":"Pollack","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.nec.2012.04.007_bib18","first-page":"1786","article-title":"Epidermal\u00a0growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood","volume":"5","author":"Bredel","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nec.2012.04.007_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1215\/15228517-2006-036","article-title":"Molecular pathogenesis of pediatric astrocytic tumors","volume":"9","author":"Nakamura","year":"2007","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.nec.2012.04.007_bib20","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1200\/JCO.2006.07.8626","article-title":"Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors","volume":"25","author":"Faury","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.nec.2012.04.007_bib21","first-page":"5254","article-title":"PTEN\/MMAC1 mutations and EGFR amplification in glioblastomas","volume":"57","author":"Liu","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.nec.2012.04.007_bib22","first-page":"1238","article-title":"Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort","volume":"50","author":"Pollack","year":"2002","journal-title":"Neurosurgery"},{"key":"10.1016\/j.nec.2012.04.007_bib23","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0002-9440(10)64103-X","article-title":"Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases","volume":"158","author":"Rickert","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nec.2012.04.007_bib24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1750-3639.2000.tb00258.x","article-title":"Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas","volume":"10","author":"Sung","year":"2000","journal-title":"Brain Pathol"},{"key":"10.1016\/j.nec.2012.04.007_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1227\/00006123-200208000-00012","article-title":"Latency between symptom onset and diagnosis of pediatric brain tumors: an Eastern Canadian geographic study","volume":"51","author":"Mehta","year":"2002","journal-title":"Neurosurgery"},{"key":"10.1016\/j.nec.2012.04.007_bib26","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1586\/14737175.7.7.875","article-title":"Diagnosis of brain tumors in children","volume":"7","author":"Duffner","year":"2007","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.nec.2012.04.007_bib27","series-title":"Diagnostic imaging brain","author":"Osborn","year":"2007"},{"key":"10.1016\/j.nec.2012.04.007_bib28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11060-011-0601-x","article-title":"Proton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma","volume":"105","author":"Steffen-Smith","year":"2011","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.nec.2012.04.007_bib29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1200\/JCO.1995.13.1.112","article-title":"Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group","volume":"13","author":"Finlay","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.nec.2012.04.007_bib30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3<497::AID-CNCR18>3.0.CO;2-S","article-title":"Supratentorial malignant gliomas in childhood: a single institution perspective","volume":"80","author":"Heideman","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.nec.2012.04.007_bib31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/cncr.10114","article-title":"Preradiation chemotherapy for pediatric patients with high-grade glioma","volume":"94","author":"Wolff","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.nec.2012.04.007_bib32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3171\/jns.1998.89.1.0052","article-title":"Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children\u2019s Cancer Group trial no. CCG-945","volume":"89","author":"Wisoff","year":"1998","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.nec.2012.04.007_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-006-9299-6","article-title":"Anaplastic mixed gliomas and anaplastic oligodendroglioma in children: results from the CCG 945 experience","volume":"83","author":"Hyder","year":"2007","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.nec.2012.04.007_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF00170946","article-title":"Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study","volume":"14","author":"Fulton","year":"1992","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.nec.2012.04.007_bib35","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/1097-0142(19930815)72:4<1414::AID-CNCR2820720442>3.0.CO;2-C","article-title":"Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A Childrens Cancer Group Phase I\/II Trial","volume":"72","author":"Packer","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.nec.2012.04.007_bib36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00165101","article-title":"The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group","volume":"7","author":"Sposto","year":"1989","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.nec.2012.04.007_bib37","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1200\/JCO.20.5.1375","article-title":"Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide","volume":"20","author":"Stupp","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.nec.2012.04.007_bib38","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1200\/JCO.1995.13.7.1687","article-title":"Prognostic\u00a0factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Childrens Cancer Group randomized trial","volume":"13","author":"Cohen","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.nec.2012.04.007_bib39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/neuonc\/noq191","article-title":"Temozolomide in the treatment of high-grade gliomas in children: a report from the Children\u2019s Oncology Group","volume":"13","author":"Cohen","year":"2011","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.nec.2012.04.007_bib40","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/neuonc\/noq205","article-title":"Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas","volume":"13","author":"Cohen","year":"2011","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.nec.2012.04.007_bib41","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/cncr.22961","article-title":"Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children\u2019s Oncology Group","volume":"110","author":"Nicholson","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.nec.2012.04.007_bib42","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1200\/JCO.2002.08.141","article-title":"Temozolomide in malignant gliomas of childhood: a United Kingdom Children\u2019s Cancer Study Group and French Society for Pediatric Oncology Intergroup Study","volume":"20","author":"Lashford","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.nec.2012.04.007_bib43","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/bjc.1998.555","article-title":"Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children\u2019s Cancer Study Group","volume":"78","author":"Estlin","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nec.2012.04.007_bib44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1096-911X(199908)33:2<83::AID-MPO4>3.0.CO;2-G","article-title":"Regimen-related toxicity of myeloablative chemotherapy with BCNU, thiotepa, and etoposide followed by autologous stem cell rescue for children with newly diagnosed glioblastoma multiforme: report from the Children\u2019s Cancer Group","volume":"33","author":"Grovas","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.nec.2012.04.007_bib45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1215\/S1152851704000304","article-title":"Sequential\u00a0chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade glioma","volume":"7","author":"Massimino","year":"2005","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.nec.2012.04.007_bib46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.bmt.1705953","article-title":"Myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for childhood central nervous system tumors","volume":"41","author":"Marachelian","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.nec.2012.04.007_bib47","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/cncr.24730","article-title":"Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol","volume":"116","author":"Wolff","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.nec.2012.04.007_bib48","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3171\/2011.5.PEDS1178","article-title":"Multidisciplinary management of childhood brain tumors: a review of outcomes, recent advances, and challenges","volume":"8","author":"Pollack","year":"2011","journal-title":"J\u00a0Neurosurg Pediatr"},{"key":"10.1016\/j.nec.2012.04.007_bib49","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1158\/1078-0432.CCR-08-3210","article-title":"EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines","volume":"15","author":"Bax","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nec.2012.04.007_bib50","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1158\/0008-5472.CAN-09-1851","article-title":"Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas","volume":"70","author":"Schiffman","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.nec.2012.04.007_bib51","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.1158\/1078-0432.CCR-11-1456","article-title":"Targeted therapy for BRAFV600E malignant astrocytoma","volume":"17","author":"Nicolaides","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nec.2012.04.007_bib52","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"363","author":"Flaherty","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.nec.2012.04.007_bib53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2009.10.010","article-title":"EGF receptor inhibitors in the treatment of glioblastoma multiform: old clinical allies and newly emerging therapeutic concepts","volume":"625","author":"Gadji","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.nec.2012.04.007_bib54","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1215\/15228517-2006-031","article-title":"Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report","volume":"9","author":"Pollack","year":"2007","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.nec.2012.04.007_bib55","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11060-010-0334-2","article-title":"High dose methotrexate for pediatric high grade glioma: results of\u00a0the HIT-GBM-D pilot study","volume":"102","author":"Wolff","year":"2011","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.nec.2012.04.007_bib56","doi-asserted-by":"crossref","first-page":"984","DOI":"10.18632\/oncotarget.362","article-title":"PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation","volume":"2","author":"van Vuurden","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.nec.2012.04.007_bib57","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pbc.22319","article-title":"Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours","volume":"54","author":"Ardon","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.nec.2012.04.007_bib58","first-page":"781","article-title":"Evaluation of antitumor activity of gefitinib in pediatric glioblastoma and neuroblastoma cells","volume":"57","author":"Hatziagapiou","year":"2011","journal-title":"Clin Lab"}],"container-title":["Neurosurgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368012000460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042368012000460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T18:10:33Z","timestamp":1642356633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1042368012000460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1042368012000460"],"URL":"https:\/\/doi.org\/10.1016\/j.nec.2012.04.007","relation":{},"ISSN":["1042-3680"],"issn-type":[{"value":"1042-3680","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}